LOCATION
Live Mayo Clinic Phoenix: Waugh Auditorium Side A and Virtual - Zoom Webinar (Contact AZ DLMP Education for meeting link)

PRESENTER

Stanley Jordan, M.D.

LEARNING OBJECTIVES

• Recognize the pathogenic aspects of cellular and antibody mediated injury to allografts.
• Describe the currently available therapeutic options to deal with antibody injury to allografts.
• Describe emerging therapies and their unique mechanisms of action in treatment of antibody mediated rejection and desensitization
• Recognize the importance of Regulatory T-cells and regulatory B-cells in maintaining allograft tolerance and how therapeutics can induce them.
• Examine the emerging clinical trials aimed at prevention and treatment of antibody-mediated rejection of the kidney.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.